Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
暂无分享,去创建一个
H. Kirikoshi | A. Nakajima | K. Kubota | M. Inamori | H. Hiraishi | M. Yoneda | T. Higurashi | Y. Nozaki | H. Mawatari | K. Fujita | N. Kobayashi | Y. Abe | S. Saito | S. Maeyama | S. Togo | M Yoneda | H Mawatari | K Fujita | H Endo | H Iida | Y Nozaki | K Yonemitsu | T Higurashi | H Takahashi | N Kobayashi | H Kirikoshi | Y Abe | M Inamori | K Kubota | S Saito | M Tamano | H Hiraishi | S Maeyama | N Yamaguchi | S Togo | A Nakajima | M. Tamano | H. Iida | H. Takahashi | H. Endo | K. Yonemitsu | N. Yamaguchi
[1] P. Bedossa,et al. Appropriateness of liver biopsy. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[2] W D Carey,et al. The role of liver biopsy in chronic hepatitis C , 2001, Hepatology.
[3] M. Fink,et al. Shear elasticity probe for soft tissues with 1-D transient elastography , 2002, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.
[4] R. Soloway,et al. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy , 1971, The American Journal of Digestive Diseases.
[5] T. Laurent,et al. Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age. , 1992, Scandinavian journal of clinical and laboratory investigation.
[6] H. Kawasaki,et al. Serum type III procollagen peptide, type IV collagen 7S domain, central triple‐helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology , 1994, Hepatology.
[7] M. Ziol,et al. 87 Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): Risk factors and diagnostic potential of liver elasticity using fibroscan , 2006 .
[8] V. de Lédinghen,et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.
[9] E. Brunt. Nonalcoholic Steatohepatitis: Definition and Pathology , 2001, Seminars in liver disease.
[10] J. Ludwig,et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. , 1980, Mayo Clinic proceedings.
[11] T. Poynard,et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.
[12] B. Balkau,et al. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. , 1994, Journal of hepatology.
[13] Llorenç Quintó,et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model , 2002, Hepatology.
[14] Z. Younossi,et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. , 1999, Gastroenterology.
[15] A. Nakajima,et al. Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD) , 2007, Gut.
[16] P. Giral,et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. , 2005, Gastroenterology.
[17] K. Batts,et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.
[18] Eugene R. Schiff,et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection , 2002, American Journal of Gastroenterology.
[19] A. Sanyal. Treatment of non‐alcoholic fatty liver disease , 2002, Journal of gastroenterology and hepatology.
[20] B. Maharaj,et al. SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.
[21] K. Ishak,et al. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. , 1988, Gastroenterology.
[22] T. Ueno,et al. Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen. , 1992, Scandinavian journal of gastroenterology.
[23] P. Angulo,et al. Nonalcoholic fatty liver disease. , 2002, Revista de gastroenterologia de Mexico.
[24] A. Sanyal,et al. AGA technical review on nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[25] F. Kinjo,et al. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. , 2005, World journal of gastroenterology.
[26] V. de Lédinghen,et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations , 2006, European journal of gastroenterology & hepatology.
[27] M. Ziol,et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.
[28] Hiroyuki Kaneda,et al. Nonalcoholic steatohepatitis: risk factors for liver fibrosis. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.
[29] Christos Christidis,et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C , 2005, Hepatology.
[30] G. Farrell. Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region? , 2003, Journal of gastroenterology and hepatology.
[31] V. Paradis,et al. Sampling variability of liver fibrosis in chronic hepatitis C , 2003, Hepatology.
[32] M. Sato. [Mechanical properties of living tissues]. , 1986, Iyo denshi to seitai kogaku. Japanese journal of medical electronics and biological engineering.
[33] E. Mezey,et al. Sampling variability on percutaneous liver biopsy. , 1979, Archives of internal medicine.
[34] H. Saito,et al. Efficacy of non-invasive elastometry on staging of hepatic fibrosis. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.
[35] Cadranel Jf. [Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future]. , 2002 .
[36] S. Yamashita,et al. Abdominal fat: standardized technique for measurement at CT. , 1999, Radiology.
[37] Plumley Pf. Letter: the consultants' contract. , 1975, Lancet.
[38] P. Giral,et al. Liver fibrosis in overweight patients. , 2000, Gastroenterology.